Sign In
Buy CTMX
$3.22
+0.0600 (+1.90%)
At Close: Jun 03, 2026
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CytomX Therapeutics, Inc. (NASDAQ: CTMX) between May 17, 2018, and May 13, 2020, inclusive (the "Class Period
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CTMX, PPC and WRCDF
05:30pm, Friday, 10'th Jul 2020
NEW YORK, NY / ACCESSWIRE / July 10, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to particip
NEW YORK, July 10, 2020 -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against CytomX.
Here's Why We're Watching CytomX Therapeutics's (NASDAQ:CTMX) Cash Burn Situation
03:34pm, Friday, 10'th Jul 2020
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Lawsuits Filed Against CONN, CTMX and SRNE - Jakubowitz Law Pursues Shareholders Claims
08:20pm, Thursday, 09'th Jul 2020
NEW YORK, NY / ACCESSWIRE / July 9, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who
LOS ANGELES, CA / ACCESSWIRE / July 9, 2020 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against CytomX Therapeutics, Inc. ("Cy
LAWSUITS FILED AGAINST R, CTMX and CLNY - Jakubowitz Law Pursues Shareholders Claims
10:50pm, Wednesday, 08'th Jul 2020
NEW YORK, NY / ACCESSWIRE / July 8, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CONN, CTMX and CCL
05:50pm, Wednesday, 08'th Jul 2020
NEW YORK, NY / ACCESSWIRE / July 8, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly-traded companies. Sh
New York, New York--(Newsfile Corp. - July 8, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in CytomX Therapeutics, Inc. ("CytomX" or the "Company") (NASDAQ:
LOS ANGELES, CA / ACCESSWIRE / July 8, 2020 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against CytomX Therapeutics, Inc. ("Cy
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CTMX, IDEX and BKD
09:30pm, Tuesday, 07'th Jul 2020
NEW YORK, NY / ACCESSWIRE / July 7, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participa
ROSEN, GLOBAL INVESTOR COUNSEL, Reminds CytomX Therapeutics, Inc. Investors of Important Deadline in Securities Class Action - CTMX
08:51pm, Tuesday, 07'th Jul 2020
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CytomX Therapeutics, Inc. (NASDAQ: CTMX) between May 17, 2018, and May 13, 2020, inclusive (the "Class Period
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of R, CTMX and WFC
03:00am, Tuesday, 07'th Jul 2020
NEW YORK, NY / ACCESSWIRE / July 6, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Sh
CLASS ACTION UPDATE for R, CTMX and ENPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
05:40pm, Monday, 06'th Jul 2020
NEW YORK, NY / ACCESSWIRE / July 6, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders
NEW YORK, NY / ACCESSWIRE / July 6, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against CytomX Therapeutics, Inc. ("CytomX" or "the ...
